Recently, several novel cascade nanoimmunomodulators, such as CMZM [77] and IMZF [78], which possess multi-enzymatic activities including SOD, CAT, POD, and OXD, have been proposed to enhance cancer immunotherapy. Here, SOD1 is linked to cancer.